Squarepoint Ops LLC

Position in DYN — Dyne Therapeutics, Inc.

CIK 1642575 NEW YORK, NY

Position in DYN

as of Mar 31, 2026 · filed May 15, 2026 Compact

Position Value

$15,123,610

+$10,132,681 QoQ

Shares Held

834,176

+226.9% QoQ

Ownership

0.584%

of shares outstanding

% of Portfolio

0.04%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Sep 2020

12 quarters on record

Voting authority Sole 0.ToString("F0")% Shared 100.ToString("F0")% None 0.ToString("F0")%

Healthcare · as of Mar 31, 2026

Squarepoint Ops LLC holds $1,099,505,720 across 232 Biotechnology names. DYN ranks #16 (1.4% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ALNY	Alnylam Pharmaceuticals, Inc.	426,723	$141,189,839
2	REGN	Regeneron Pharmaceuticals, Inc.	162,814	$125,796,608
3	RPRX	Royalty Pharma plc	1,349,516	$64,736,282
4	IONS	Ionis Pharmaceuticals Inc	695,276	$52,208,274
5	BBIO	BridgeBio Pharma, Inc.	556,324	$41,312,620
6	MDGL	Madrigal Pharmaceuticals, Inc.	52,884	$27,683,187
7	ARQT	Arcutis Biotherapeutics, Inc.	1,103,490	$25,998,224
8	FOLD	AMICUS THERAPEUTICS, INC.	1,705,829	$24,666,287

12 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$15,123,610	834,176	+226.9%	Shares	Defined	2026-05-15
2025-12-31	$4,990,929	255,160	+436.1%	Shares	Defined	2026-02-13
2025-09-30	$602,038	47,592	-73.8%	Shares	Defined	2025-11-14
2025-06-30	$1,730,164	181,740	+334.3%	Shares	Defined	2025-08-27
2025-03-31	$437,688	41,844	-18.9%	Shares	Defined	2025-08-27
2024-12-31	$1,216,072	51,616	-38.0%	Shares	Defined	2025-02-14
2024-09-30	$2,989,585	83,229	+84.2%	Shares	Defined	2024-11-14
2024-06-30	$1,594,966	45,196	-42.9%	Shares	Defined	2024-08-14
2024-03-31	$2,247,920	79,180	+132.5%	Shares	Defined	2024-05-15
2023-06-30	$383,208	34,063	+39.8%	Shares	Defined	2023-08-14
2023-03-31	$280,650	24,362	+5.1%	Shares	Defined	2023-05-15
2020-09-30	$467,883	23,174	—	Shares	Defined	2020-11-16
No filing history on record for this holder in this stock.